The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Lupus Erythematosus

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Rheumatology (Oxford)

Onishi A, Tsuji H, Sasai T, Shirakashi M, Hiwa R, Nakabo S, Akizuki S, Nakashima R, Nishimura K, Sada KE, Miyawaki Y, Umeda M, Yoshimi R, Ohno S, Yajima N, Kajiyama H, Sato S, Kishida D, Fujiwara M, Kida T, Matsuo Y, Takatani A, Onishi T, Ida T, Umekita K, Miyake H, Nakano H, Ikeda K, Ichinose K, Yoshifuji H, Tanaka M, Morinobu A

doi: 10.1093/rheumatology/keag080

Systemic Lupus Erythematosus

Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes

J Rheumatol

Zaffino I, Boulard L, Law J, Danguecan A, Jeyanathan A, Ng L, Williams-Reid S, Reid K, Cortes A, Cortes E, Levy DM, Hiraki LT, Knight AM

doi: 10.3899/jrheum.2025-0375

Systemic Lupus Erythematosus

Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study

Semin Arthritis Rheum

Sagy I, Shitrit I, Abuhasira R, David RB, Haviv YS, Tayer-Shifman O, Abu-Shakra M, Brav E, Burrack N, Zeller L

doi: 10.1016/j.semarthrit.2025.152746

Rheumatoid ArthritisSystemic Lupus Erythematosus

The Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost among Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients: A Population-based Study

Arthritis Rheumatol

Hoque MR, Lacaille D, Aviña-Zubieta JA, De Vera MA, Qian Y, McCandless L, Esdaile JM, Xie H

doi: 10.1002/art.70071

Systemic Lupus Erythematosus

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Ann Rheum Dis

Branch DW, Kim MY, Guerra MM, Worden J, Laskin CA, DeSancho MT, Landres IV, Knight JS, Slosberg HS, Minett M, Salmon JE

doi: 10.1016/j.ard.2025.02.012

Systemic Lupus Erythematosus

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

Arthritis Res Ther

Kojima K, Ichinose K, Umeda M, Shimizu T, Sato S, Suzuki T, Nakashima Y, Okada A, Horai Y, Fujikawa K, Aramaki T, Miyashita T, Furuyama M, Matsuoka N, Kawakami A

doi: 10.1186/s13075-025-03581-0

Systemic Lupus Erythematosus

The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes

J Rheumatol

Benson KRK, Becerril A, Park J, Plantinga L, Yazdany J, Dall'Era M, Katz PP

doi: 10.3899/jrheum.2025-0631

Systemic Lupus Erythematosus

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Rheumatology (Oxford)

Miyake H, Kida T, Yoshimi R, Michizu Y, Nishimura K, Sada KE, Miyawaki Y, Matsuo Y, Ohno S, Kajiyama H, Sato S, Shimojima Y, Fujiwara M, Takatani A, Onishi T, Katsushima M, Ida T, Umekita K, Nakano H, Ikeda K, Ichinose K, Onishi A

doi: 10.1093/rheumatology/keaf504

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes

Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study

The Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost among Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients: A Population-based Study

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study